Company Announcements In July, investment-firm StoneCalibre acquired Edge Biosystems, a manufacturer and distributor of sample preparation and clean-up products for sequencing. Pressure Bioscience entered into a strategic R&D agreement with Parabase Genomics to develop a sample preparation method for Parabase’s neonatal molecular diagnostics and newborn confirmatory-testing process. Cypher Genomics announced a copromotion agreement with Illumina […]
Company Announcements For the first six months, sales for Mettler-Toledo‘s Laboratory business grew 6% excluding currency to roughly $533 million to account for 46% of revenues. First and second quarter Laboratory sales advanced 7% and 6% excluding currency, respectively. Sales growth was driven by increased demand and favorable pricing for analytical instruments and laboratory balances. […]
An unfortunate consequence of the recent explosion in next-generation sequencing (NGS) activity is the huge amount of generated data that are unused or not used to their full potential. Analysis of sequence data can take orders of magnitude more time than producing it and, as a result, is unable to keep pace. The existence of […]
San Diego, CA 8/21/14; London, England 8/21/14—Illumina has formed collaborative partnerships with AstraZeneca, Janssen Biotech and Sanofi to develop a universal next-generation sequencing (NGS)–based oncology test system. The system will be used for clinical trials of targeted cancer therapies with a goal of developing and commercializing a multigene panel for therapeutic selection. The partnership involves […]
As part of its move into the clinical market, Illumina has formed a collaboration with pharmaceutical companies AstraZeneca, Janssen Biotech and Sanofi to develop a companion-diagnostic test for oncology based on next-generation sequencing (NGS) (see page 2). Intending to extend the partnership to additional companies, Illumina plans to develop the Universal Oncology Test System, to […]
Company Announcements In May, Igenbio opened an office in Japan. In June, One Lambda, a Thermo Fisher Scientific company, gained exclusive rights to GenoDive Pharma’s long-range primers and amplification conditions for HLA-locus–specific amplification in order to develop an IVD next-generation sequencing (NGS) kit. Rubicon Genomics added multiple European distributors, including Cambridge Bioscience for the UK […]
San Diego, CA 7/16/14—Illumina has purchased Myraqa, a regulatory and quality consulting firm that specializes in IVD, particularly companion diagnostics. The purchase price was undisclosed. Illumina stated that the acquisition adds to its in-house capabilities for clinical readiness and prepares it for its next growth phase in regulated markets. “With Myraqa, Illumina will continue to […]
Company Announcements Personal Genomics announced in April an exclusive sales alliance for Knome’s knoSYS platform in Italy. Under a distribution agreement, Bina Technologies will include runtime licenses for Appistry’s Genome Analysis Toolkit and Cancer Genome Analysis Suite analysis tools as part of its Bina Analytical genomics platform. First quarter Pacific Biosciences sales soared 108.7% to […]
IVD relies on a number of technologies to test for certain conditions, diseases and infections. Molecular diagnostic (MDx) tests use genomic and proteomic technologies for such analyses. The February 2014 Strategic Directions International report, “The Coveted Molecular Diagnostics Market: From Clinical Research to Diagnosis and Personalized Medicine—Innovative Technologies Break Through,” covers the use of nucleic […]
Pleasanton, CA 6/26/14—Roche has made a strategic investment in Stratos Genomics and will collaborate with the company on research related to Stratos’s chemistry for single-molecule sequencing of DNA fragments using protein nanopores. The companies will work to develop efficient, low-cost sample preparation methods for DNA Xpandomers, a larger surrogate molecule, and to improve sequencing performance. […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
